Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 58

Results For "Pharmaceutical"

3985 News Found

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026
Policy | June 12, 2026

Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026

Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance


India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM
News | June 12, 2026

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion


Biopharma SHAKTI envisages launch of 100 biologics by 2047:  Anupriya Patel
Policy | June 12, 2026

Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel

The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi


Govt approval to KIHT as CRO expands India’s innovation capabilities
Clinical Trials | June 12, 2026

Govt approval to KIHT as CRO expands India’s innovation capabilities

KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation


Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
People | June 11, 2026

Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager

Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions


Glenmark launches Winlevi across key European markets
News | June 11, 2026

Glenmark launches Winlevi across key European markets

First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe


Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
News | June 11, 2026

Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies

The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy


DFE Pharma wins third straight EcoVadis Gold Medal
News | June 11, 2026

DFE Pharma wins third straight EcoVadis Gold Medal

The award places the company in the top 5% globally


Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules
Drug Approval | June 11, 2026

Alembic Pharma receives USFDA tentative approval for generic Larotrectinib capsules

Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions